Batten Disease | ASGCT - American Society of Gene & Cell Therapy |

<!DOCTYPE html> <html xmlns="http://www.w3.org/1999/xhtml"> <head>  <script type="text/javascript">(function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-NFW5DS9');</script>   <script type="text/javascript"> //------------------------------------------------------- var z_account = "2632C1D8-6432-4D3A-93D6-08AAECC53F86"; var z_collector = "asgct.informz.net"; var z_cookieDomain = ".asgct.org"; //------------------------------------------------------- (function (e, o, n, r, t, a, s) { e[t] || (e.GlobalSnowplowNamespace = e.GlobalSnowplowNamespace || [], e.GlobalSnowplowNamespace.push(t), e[t] = function () { (e[t].q = e[t].q || []).push(arguments) }, e[t].q = e[t].q || [], a = o.createElement(n), s = o.getElementsByTagName(n)[0], a.async = 1, a.src = r, s.parentNode.insertBefore(a, s)) }(window, document, "script", "https://cdn.informz.net/web_trk/sp.js", "informz_trk")), informz_trk("newTracker", "infz", z_collector + "/web_trk/collector/", { appId: z_account, cookieDomain: z_cookieDomain }), informz_trk("setUserIdFromLocation", "_zs"), informz_trk("enableActivityTracking", 30, 15); informz_trk("trackPageView", null); </script>  <meta charset="utf-8" /> <meta http-equiv="X-UA-Compatible" content="IE=edge" /> <meta name="viewport" content="width=device-width,user-scalable=no,maximum-scale=1.0,initial-scale=1.0" /> <link href="/BlueKey/pe_assets/build/styles.css" rel="stylesheet" /> <script type="text/javascript" defer="defer" src="https://extend.vimeocdn.com/ga/127349852.js"></script> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:site" content="https://twitter.com/ASGCTherapy" <meta name="twitter:creator" content="@ASGCTherapy" <meta name="twitter:title" content="Batten Disease" <meta name="twitter:description" content="Each form of Batten is linked to a specific faulty gene that leads to waste buildup in cells." <meta name="twitter:image" content="~/getattachment/Disease-Treatments/Batten/Batten_Disease_330x230_4_00000.png.aspx" <meta name="description" content="Batten disease is the common name for a group of rare genetic disorders that affect the nervous system." /> <meta charset="UTF-8" /> <link href="/App_Themes/Default/Images/favicon.ico" type="image/x-icon" rel="shortcut icon" /> <link href="/App_Themes/Default/Images/favicon.ico" type="image/x-icon" rel="icon" /> <title> Batten Disease | ASGCT - American Society of Gene & Cell Therapy | </title></head> <body class="LTR IE IE7 ENUS ContentBody">  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NFW5DS9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>  <form method="post" action="/disease-treatments/batten" id="aspnetForm"> <div class="aspNetHidden"> <input type="hidden" name="__CMSCsrfToken" id="__CMSCsrfToken" value="HRovPeESNBXI/TRonNAmHC0sc9bTmUeEUMywt9BLnGy8T4pQztawm1qljk7iqVpkBpoGk2cBlDm8hIRq0oO9/2IivU8=" /> <input type="hidden" name="__EVENTTARGET" id="__EVENTTARGET" value="" /> <input type="hidden" name="__EVENTARGUMENT" id="__EVENTARGUMENT" value="" /> <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" /> </div> <script type="text/javascript"> //<![CDATA[ var theForm = document.forms['aspnetForm']; if (!theForm) { theForm = document.aspnetForm; } function __doPostBack(eventTarget, eventArgument) { if (!theForm.onsubmit || (theForm.onsubmit() != false)) { theForm.__EVENTTARGET.value = eventTarget; theForm.__EVENTARGUMENT.value = eventArgument; theForm.submit(); } } //]]> </script> <script src="/WebResource.axd?d=UZQNzmZXG1IdUaHxtavOjRvGEvOmz1kvw97PqEaxzBy7Ys-tUotw-RqgdbsvC3g_7cXjehqAdA_N6kbuK73WBAVGdxo1&t=638562384440000000" type="text/javascript"></script> <input type="hidden" name="lng" id="lng" value="en-US" /> <script type="text/javascript"> //<![CDATA[ function PM_Postback(param) { if (window.top.HideScreenLockWarningAndSync) { window.top.HideScreenLockWarningAndSync(1080); } if(window.CMSContentManager) { CMSContentManager.allowSubmit = true; }; __doPostBack('ctl00$CMSPortalManager1$am',param); } function PM_Callback(param, callback, ctx) { if (window.top.HideScreenLockWarningAndSync) { window.top.HideScreenLockWarningAndSync(1080); }if (window.CMSContentManager) { CMSContentManager.storeContentChangedStatus(); };WebForm_DoCallback('ctl00$CMSPortalManager1$am',param,callback,ctx,null,true); } //]]> </script> <script src="/ScriptResource.axd?d=WTJtoz6EJe-loUBJ9stbRxqzgpVp8oo0KdZGkhGfcu6Lr7kb5LeNfx21FKi8mxEL1oDZOLAxiAqERpClgBx-A6lZ0DJ1qKcDZB1NuIbRd8o9S7aG0&t=7c776dc1" type="text/javascript"></script> <script src="/ScriptResource.axd?d=y6KGkkRaceYF_mkApXCXMQ_rMQVX59BlJ-ut-lQDHw88bR5bbS86epdVNwimj01duE6_OophLX4sBTOgb8_5dNLaY2Mx5DHMJj7Rbr4kPMV1-AOS5VF5-QEC8oG-_-aHoWoyqA2&t=7c776dc1" type="text/javascript"></script> <script type="text/javascript"> //<![CDATA[ var CMS = CMS || {}; CMS.Application = { "isDialog": false, "isDebuggingEnabled": false, "applicationUrl": "/", "isRTL": "false", "imagesUrl": "/CMSPages/GetResource.ashx?image=%5bImages.zip%5d%2f" }; //]]> </script> <div class="aspNetHidden"> <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="2CD64FB1" /> <input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEdAANuwkvkBXIX/bGl7KHtmElNDMN6QAizBz4KoPbUd79oAZD1NQdfl/cWuar5Vh7dGPS+KwfUwXvSdeoEXepHk+a6gihRfA==" /> </div> <script type="text/javascript"> //<![CDATA[ Sys.WebForms.PageRequestManager._initialize('ctl00$manScript', 'aspnetForm', ['tctl00$ctxM',''], [], [], 90, 'ctl00'); //]]> </script> <div id="ctl00_ctxM"> </div> <header class="c-header"> <a href="#content" class="show-on-focus">Skip to main content</a> <div class="c-header-utilities"> <div class="container"> <div class="columns is-vcentered"> <div class="column"> <a href="https://asgct.org" class="is-external">ASGCT.org</a> </div> <div class="column is-half"> <a href="/"> <div class="c-header-images"> <div class="c-header-image"> <img src="/PatientEducation/media/PatientEducation/ASGCT_Web_Horz_Navy.png?ext=.png" alt="" /> </div> <div class="c-header-image"> <img src="/PatientEducation/media/PatientEducation/temp-pe-logo.png?ext=.png" alt="Patient Education Logo" /> </div> </div> </a> </div>  <div class="column"> <div class="c-header-search"> <div class="c-header-search-wrap"> <input name="keyword" type="text" id="searchtext" placeholder="Search" aria-required="false" /> <label for="searchtext" class="is-sr-only">Keyword search</label> <button type="button" data-encode="searchtext" data-path="/search-results" data-query="searchtext"> <span class="is-sr-only">Search</span> <span class="c-search-icon"></span> </button> </div> </div> </div> </div> </div> </div> <div class="c-header-utilities-mobile"> <div class="c-header-images"> <div class="c-header-image"> <a href="https://asgct.org" class="is-external"><img src="/PatientEducation/media/PatientEducation/ASGCT_Web_Horz_Navy.png?ext=.png" alt="" /></a> </div> <div class="c-header-image"> <a href="/"><img src="/PatientEducation/media/PatientEducation/temp-pe-logo.png?ext=.png" alt="Patient Education Logo" /></a> </div> </div> <button class="c-nav-toggle" type="button" aria-controls="c-nav-main" aria-expanded="false" data-togglevisibility="data-togglevisibility"> <p class="is-sr-only">Open Navigation</p> <p class="is-sr-only" aria-hidden="true">Close Navigation</p> <span class="c-nav-toggle-menu"></span> </button> </div> <div id="ctl00_plcMain_bkSiteHeader_headerBanner"> <div class="header-alert"> <div class="container"> <p id="ctl00_plcMain_bkSiteHeader_pBanner"><b><a href="https://patienteducation.asgct.org/newsletter/subscribe-to-the-patient-press">Subscribe today to ASGCT's patient-centered newsletter, The Patient Press!</a></b></p> </div> </div> </div> <nav class="c-nav-main" id="c-nav-main" aria-hidden="true"> <div class="container"> <div class="c-header-search is-hidden-desktop"> <div class="c-header-search-wrap"> <input name="" type="text" id="global-search" placeholder="Search" aria-required="false" /> <label for="global-search" class="is-sr-only">Keyword search</label> <button type="button" data-encode="global-search" data-path="/search-results" data-query="searchtext"> <span class="is-sr-only">Search</span> <span class="c-search-icon"></span> </button> </div> </div> <ul> <li> <a href="/gene-therapy-101">Gene & Cell Therapy 101</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/gene-therapy-101/gene-therapy-basics">Gene Therapy Basics</a> </li> <li> <a href="/gene-therapy-101/cell-therapy-basics">Cell Therapy Basics</a> </li> <li> <a href="/gene-therapy-101/gene-therapy-approaches">Gene Therapy Approaches</a> </li> <li> <a href="/gene-therapy-101/gene-editing">Gene Editing</a> </li> <li> <a href="/gene-therapy-101/clinical-trials">Clinical Trials</a> </li> <li> <a href="/gene-therapy-101/vectors-101">Vectors 101</a> </li> <li> <a href="/gene-therapy-101/glossary">Glossary</a> </li> <li> <a href="/gene-therapy-101/covid19-vaccines">COVID-19</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/disease-treatments">Condition Treatments</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/disease-treatments/fda-approved-cell-gene-therapy-products">FDA-Approved Cell & Gene Therapy Products</a> </li> <li> <a href="/disease-treatments/batten">Batten Disease</a> </li> <li> <a href="/disease-treatments/blood-disorders">Beta Thalassemia & Other Blood Disorders</a> </li> <li> <a href="/disease-treatments/leukodystrophy">CALD and MLD</a> </li> <li> <a href="/disease-treatments/car-t-basics">CAR-T Basics</a> </li> <li> <a href="/disease-treatments/fabry">Fabry Disease</a> </li> <li> <a href="/disease-treatments/gaucher-disease">Gaucher Disease</a> </li> <li> <a href="/disease-treatments/gm1-gangliosidosis">GM1 Gangliosidosis</a> </li> <li> <a href="/disease-treatments/gm2-tay-sachs-sandhoff">Tay-Sachs and Sandhoff Disease</a> </li> <li> <a href="/disease-treatments/hemophilia">Hemophilia</a> </li> <li> <a href="/disease-treatments/huntingtons-disease">Huntington's Disease</a> </li> <li> <a href="/disease-treatments/inherited-retinal-diseases">Inherited Retinal Diseases</a> </li> <li> <a href="/disease-treatments/mps">Mucopolysaccharidoses (MPS)</a> </li> <li> <a href="/disease-treatments/muscular-dystrophy">Muscular Dystrophy</a> </li> <li> <a href="/disease-treatments/pompe-disease">Pompe Disease</a> </li> <li> <a href="/disease-treatments/parkinsons-disease">Parkinson's Disease</a> </li> <li> <a href="/disease-treatments/sickle-cell-disease">Sickle Cell Disease</a> </li> <li> <a href="/disease-treatments/sma">Spinal Muscular Atrophy</a> </li> <li> <a href="/disease-treatments/wilson-disease">Wilson Disease</a> </li> <li> <a href="/disease-treatments/xlmtm">X-Linked Myotubular Myopathy</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/patient-journey">Patient Journey</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/patient-journey/identifying-a-genetic-disease">Identifying a Genetic Disease</a> </li> <li> <a href="/patient-journey/next-steps-with-a-diagnosis">Next Steps With a Diagnosis</a> </li> <li> <a href="/patient-journey/patient-focused-policy-positions">Patient-Focused Policy Positions</a> </li> <li> <a href="/patient-journey/stimulating-research">Stimulating Research</a> </li> <li> <a href="/patient-journey/considering-a-clinical-trial">Considering a Clinical Trial</a> </li> <li> <a href="/patient-journey/ethical-issues-germline-gene-editing">Ethical Issues: Germline Gene Editing</a> </li> <li> <a href="/patient-journey/ethical-issues-illegitimate-clinical-trials">Ethical Issues: Unproven Stem Cell Products</a> </li> <li> <a href="/patient-journey/gene-therapy-centers">Gene Therapy Centers</a> </li> <li> <a href="/patient-journey/clinical-trials-finder">Clinical Trials Finder</a> </li> <li> <a href="/patient-journey/on-demand">On Demand Webinars</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/newsletter">Newsletter</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/newsletter/subscribe-to-the-patient-press">Subscribe to The Patient Press</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/quick-takes">Quick Takes</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/quick-takes/focused-ultrasound-in-cell-and-gene-therapies">Focused Ultrasound in CGTs</a> </li> <li> <a href="/quick-takes/access-to-approved-cell-and-gene-therapies">Access to Approved CGTs</a> </li> <li> <a href="/quick-takes/informed-consent">Informed Consent</a> </li> <li> <a href="/quick-takes/state-of-the-field-cgt-highlights-and-approvals-20">State of the Field: CGT Highlights and Approvals of 2023</a> </li> <li> <a href="/quick-takes/genetic-testing-and-clinical-trial-eligibility">Genetic Testing and Clinical Trial Eligibility</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/events">Events</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/events/empowering-patients-2025-a-cell-and-gene-therapies">Empowering Patients 2025: A Cell and Gene Therapies Summit</a> </li> <li> <a href="/events/annual-meeting-patient-advocate-offerings">Annual Meeting-Patient Advocate Offerings</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/about-asgct">About</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/about-asgct/overview">Overview</a> </li> <li> <a href="/about-asgct/about-asgct">About ASGCT</a> </li> <li> <a href="/about-asgct/news">ASGCT News</a> </li> <li> <a href="/about-asgct/privacy-policy">Privacy Policy</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/support">Support</a> </li> </ul> <a href="asgct.org" class="px-1 is-external is-hidden-desktop">ASGCT.org</a> </div> </nav> <div class="c-banner" style="background: url('/getattachment/Disease-Treatments/Batten/Batten_Disease_1280x720_4_00000.png.aspx') 50%/cover no-repeat;"> <div class="c-banner-content container"> <h1>Batten Disease</h1> </div> </div> </header> <main class="c-main" id="content"> <section class="c-breadcrumbs"> <div class="container"> <span><a href="/">Home</a> > </span> <a href="/disease-treatments" title="Condition Treatments" class="CMSBreadCrumbsLink">Condition Treatments</a> > <span class="CMSBreadCrumbsCurrentItem">Batten Disease</span> </div> </section> <section class="section"> <div class="container"> <div class="columns"> <div class="column is-8"> <div class="c-leader"> </div> <div class="content mb-6"> <p>Batten disease is the common name for a group of rare genetic disorders that affect the nervous system. Each form of Batten is linked to a specific faulty gene that leads to waste buildup in cells. Without the correct gene, lysosomes are not able to function properly to remove waste. This leads to rapid and progressive decline including impairments to vision, speech, movement, and thinking ability, seizures, and eventually premature death. This group of inherited lysosomal disorders is also known as neuronal ceroid lipofuscinoses, or NCLs. Gene therapy may offer a one-time treatment to slow or ideally stop the progression of these disorders by delivering a working gene to target the cause of the disease.</p> <p><iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="315" src="https://www.youtube.com/embed/5_VdzpOa0zw" width="560"></iframe></p> <h2>Batten Disease and Gene Therapy</h2> <p><a href="https://asgct.org/global/documents/patient-ed-infographics/sept-launch-website-material/batten-disease-and-gene-therapy.aspx" target="_blank"><img alt="" src="https://asgct.org/getmedia/9c16dc98-5abf-4d48-87e4-49976631d83b/Batten-infographic.aspx?width=350&height=350" style="width: 350px; height: 350px; float: right; margin: 5px 10px;" /></a>Batten disease occurs when at least one of the 13 known ceroid lipofuscinosis (CLN) genes is mutated. These genes are classified by different numbers such as CLN1, CLN2, and so on. Our lysosomes are a part of our cells that function as the “recycling center” because they help to break down and remove waste like fats and sugars. Faulty genes linked to Batten disease cause deficiencies in key enzymes within lysosomes, leading to the buildup of waste in lysosomes and injury to tissues and cells, particularly within the central nervous system. The affected CLN gene also determines the age of symptom onset and rate of progression.</p> <p>Gene therapy delivers a functional version of the faulty gene into cells, giving it instructions to produce the proteins needed to restore lysosomal function. To deliver this working gene, a vector is used, which is like an envelope carrying a message. The vector is derived from a virus because viruses are good at getting into cells. For safety, all viral genes are removed and the vector is modified to only deliver therapeutic genes into the cells. The gene therapy would typically be administered via injection to the central nervous system, such as to the spinal cord. The new genes then instruct cells to produce the correct proteins and restore proper lysosomal function.</p> <h2>Treatment Pipeline</h2> <p>It’s important to note that there is no “one size fits all'' gene therapy approach that could target all thirteen forms of the disease, as each form is linked to a different faulty CLN gene. The current forms of the disease being researched in preclinical and clinical studies are CLN1, 2, 3, 5, 6, 7 and 8. Research and development of these therapies is being done by companies including Amicus, REGENXBIO, Neurogene, Spark, and Abeona.</p> <p>To stay up to date on active and recruiting human clinical trials that may become available in the U.S. or globally, visit the <a href="https://app.emergingmed.com/asgct/home/">ASGCT Clinical Trials Finder</a>.</p> <h2>Existing Treatments</h2> <p>There is an approved enzyme replacement therapy that is an option for only one form of Batten disease, which can help restore the proper breakdown of waste materials within the lysosomes. It also requires lifelong administration, which can be required as often as every two weeks via intravenous (IV) infusion. The effectiveness of enzyme replacement therapy can vary based on age and additional medical needs. Not all forms of Batten are caused by faulty enzymes, so replacement therapy isn’t a universal option.</p> <h2>Availability</h2> <p>There are ongoing gene therapy clinical trials for some forms of Batten disease, while other forms of the disease are in the early stages of research, also known as preclinical studies. This is a necessary <a href="/gene-therapy-102/clinical-trials-process">phase of research</a> that establishes the safety and effectiveness of a treatment in animal or cell-based models before proceeding with human clinical trial investigation. Eligibility for a trial is based on strict inclusion and exclusion criteria, which is an important way for researchers to understand if the gene therapy is working properly and to ensure participant safety. For example, the clinical trials currently available target early-onset forms of the disease, so a child’s age is a determinant of potential participation. Other inclusion criteria may include having the ability to walk, and not having received a stem cell or bone marrow transplant. It is important to consult your treating physician before <a href="/clinical-trials/considering-a-clinical-trial">considering clinical trial participation.</a></p> <h2>Get Involved</h2> <p>Getting involved with patient advocacy organizations is a great way to connect with other families and people affected by Batten Disease. These organizations can provide useful resources, guidance, and often advocate for treatment research. The diseases may be rare, but you and your family are not alone.</p> <ul> <li><a href="https://www.bdsra.org/" target="_blank">Batten Disease Support and Research Association</a> </li> <li><a href="https://beyondbatten.org/" target="_blank">Beyond Batten Disease Foundation</a> </li> <li><a href="http://www.bdfa-uk.org.uk/" target="_blank">Batten Disease Family Association UK</a> </li> <li><a href="https://taylorstale.org/" target="_blank">Taylor’s Tale</a></li> <li><a href="https://www.battenfighter.com/" target="_blank">Garrett the Grand Batten Fighter</a> </li> <li><a href="https://www.noahshope.com/" target="_blank">Noah’s Hope</a></li> <li><a href="https://www.milasmiracle.org/" target="_blank">Mila's Miracle Foundation</a></li> <li><a href="https://www.beeforbattens.org/" target="_blank">Bee for Battens</a></li> <li><a href="https://www.saoirsefoundation.com/" target="_blank">The Saoirse Foundation</a></li> </ul> </div> </div> <div class="column is-4 pl-4"> <div class="c-nav-local-wrap"> <div class="asideBox"> <h3> Related Pages</h3> <hr class="is-secondary" /> <ul class="c-nav-local-list"> <li class="c-nav-local-item"><a class="c-nav-local-link" href="/disease-treatments/fda-approved-cell-gene-therapy-products">FDA-Approved Cell & Gene Therapy Products</a> </li> <li class="c-nav-local-item"><a class="c-nav-local-link" href="/disease-treatments/gaucher-disease">Gaucher Disease</a> </li> </ul> </div> </div> </div> </div> </div> <div class="lastUpdatedTag"> <p>Last Updated: 08/18/2021</p> </div> </section> </main> <footer class="c-footer"> <div class="c-footer-primary"> <section class="section"> <div class="container"> <div class="columns"> <div class="column c-footer-section"> <p><img alt="" src="/PatientEducation/media/PatientEducation/logo_white.png" /></p> <p>20800 Swenson Dr., Suite 300<br /> Waukesha, WI 53186</p> </div> <div class="column is-two-fifths c-footer-section"> <ul class="c-utility-list"> <li><a href="#">Gene Therapy 101</a></li> <li><a href="#">Disease Treatments</a></li> <li><a href="#">Clinical Trials</a></li> <li><a href="/patient-journey">Patient Journey</a></li> <li><a href="/about-asgct">About</a></li> <li><a href="/support">Support</a></li> <li><a href="https://asgct.org/about/privacy-policy" target="_blank">Privacy Policy</a></li> </ul> </div> <div class="column c-footer-section"> <h3 class="mb-3">Connect with ASGCT</h3> <p class="mb-0"><span>Phone: 414</span>.278.1341</p> <p><a href="mailto:info@asgct.org">info@asgct.org</a></p> <p> <div class="c-social"> <ul class="c-social-list"> <li class="c-social-item"><a href="https://twitter.com/ASGCTherapy" target="_blank" class="c-social-link twitter"><span class="is-sr-only">Twitter</span></a></li> <li class="c-social-item"><a href="https://www.facebook.com/ASGCTherapy" target="_blank" class="c-social-link facebook"><span class="is-sr-only">Facebook</span></a></li> <li class="c-social-item"><a href="https://www.instagram.com/asgctherapy" target="_blank" class="c-social-link instagram"><span class="is-sr-only">Instagram</span></a></li> <li class="c-social-item"><a href="https://www.linkedin.com/company/asgct" target="_blank" class="c-social-link linkedin"><span class="is-sr-only">LinkedIn</span></a></li> <li class="c-social-item"><a href="https://www.youtube.com/user/ASGCT" target="_blank" class="c-social-link youtube"><span class="is-sr-only">YouTube</span></a></li> </ul> </div> </p> </div> </div> </div> </section> </div> <div class="c-footer-secondary"> <section class="section py-4"> <div class="container"> <div class="columns"> <div class="column"> <p class="is-small">© 2024 All rights reserved. American Society of Gene & Cell Therapy.</p> <p class="is-tiny">Web design by <a href="https://www.reasononeinc.com/kentico" target="_blank">Reason One</a>. Powered by <a href="http://www.kentico.com" target="_blank">Kentico</a>.</p> </div> </div> </div> </section> </div> </footer> <div class="CookieConsent"> <span id="ctl00_cookieLawQ_lblText" class="ConsentText">This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.</span> <span class="ConsentButtons"> <input type="submit" name="ctl00$cookieLawQ$btnAllowSpecific" value="OPT OUT" id="ctl00_cookieLawQ_btnAllowSpecific" class="ConsentButton btn btn-default" /> <input type="submit" name="ctl00$cookieLawQ$btnAllowAll" value="ACCEPT" id="ctl00_cookieLawQ_btnAllowAll" class="ConsentButton btn btn-default" /> </span> </div> <script src="/BlueKey/pe_assets/build/main.js" type="text/javascript"></script> <script type="text/javascript"> //<![CDATA[ var callBackFrameUrl='/WebResource.axd?d=nNME_ObE2oIDm535eYM9xWmIMy-HXBVdo54Ly6sA5tAYPS1aA-gFDzodlP9ijTBRgmjStONrH4-ISuRTp7slHiYkACw1&t=638562384440000000'; WebForm_InitCallback();//]]> </script> </form> </body> </html>

CINXE.COM

Batten Disease | ASGCT - American Society of Gene & Cell Therapy |